BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

5 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Pharmacological inhibition of KDM5A for cancer treatment.EBI
Ningbo University
Recent Advances with KDM4 Inhibitors and Potential Applications.EBI
St. Jude Children'S Research Hospital
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.BDB
University of Oxford
Structural analysis of human KDM5B guides histone demethylase inhibitor development.BDB
University of Oxford
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.BDB
Emory University